SEC Company Response from NextCure, Inc. (NXTC) (CIK 0001661059) (NXTC) — Nov 12, 2019
NextCure, Inc. (NXTC) (CIK 0001661059)
Date: Nov. 12, 2019 · CIK: 0001661059 · Accession: 0001104659-19-062672
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234639
Letter
Re: NextCure, Inc.
November 12, 2019
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Gregory Dundas
Registration Statement on Form S-1 (File No. 333-234639)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 5:00 p.m. Eastern Time, on Thursday, November 14, 2019 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
MORGAN STANLEY & CO. LLC
Show Raw Text
CORRESP 1 filename1.htm November 12, 2019 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Gregory Dundas Re: NextCure, Inc. Registration Statement on Form S-1 (File No. 333-234639) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 5:00 p.m. Eastern Time, on Thursday, November 14, 2019 or as soon thereafter as practicable. [Signature page follows] Very truly yours, MORGAN STANLEY & CO. LLC BOFA SECURITIES, INC. PIPER JAFFRAY & CO. As representatives of the Underwriters MORGAN STANLEY & CO. LLC By: /s/ Chris Rigoli Name: Chris Rigoli Title: Vice President BOFA SECURITIES, INC. By: /s/ Greg Butz Name: Greg Butz Title: Managing Director PIPER JAFFRAY & CO. By: /s/ Chad Huber Name: Chad Huber Title: Managing Director [Signature Page to NextCure, Inc. Acceleration Request]